Erratum: TGF-ß-regulated tyrosine phosphatases induce lymphocyte apoptosis in Leishmania donovani-infected hamsters (Immunology and Cell Biology (2011) 89 (466-474) DOI:10.1038/icb.2010.108);TGF-Β-regulated tyrosine phosphatases induce lymphocyte apoptosis in Leishmania donovani-infected hamsters

Immunology and Cell Biology

Volumn 89, Issue 3, 2011, Pages 466-474

  Banerjee, Rajdeep ^a   Kumar, Sudeep ^a   Sen, Abhik ^a   Mookerjee, Ananda ^a   Roy, Syamal ^a   Pal, Subrata ^a   Das, Pradeep ^a  

^a RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

apoptosis; hamster; leishmaniasis; lymphocyte; phosphatase; TGF b

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CONCANAVALIN A; CYTOCHROME C; DNA; PROTEIN TYROSINE PHOSPHATASE; TRANSFORMING GROWTH FACTOR BETA; VANADATE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; CYTOSOL; DISEASE COURSE; DNA DEGRADATION; DNA FRAGMENTATION; ENZYME ACTIVATION; FEMALE; HAMSTER; LEISHMANIA DONOVANI; LEISHMANIASIS; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

CRICETINAE; LEISHMANIA DONOVANI;

EID: 79952814692     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.149     Document Type: Erratum

References (44)

1. Carvalho EM, Teixeira RS, Johnson Jr WD. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 1981; 33: 498-500.
2. Halder JP, Ghose S, Saha KC, Ghose AC Cell-mediated immune response in Indian kala-azarand post-kalaazardermal leishmaniasis. Infect Immun 1983; 42: 702-707. (Pubitemid 14230268)
3. Ho M, Koech DK, Iha DH, Bryceson ADM. Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol 1983; 51: 207-214. (Pubitemid 13177542)
4. Murray HW. Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother 2001; 45: 2185-2197. (Pubitemid 32664455)
5. Bodgan C, Röllinghoff M. The immune responseto Leishmania: mechanismsof parasite control and evasion. Int J Parasitol 1998; 28: 121-134. (Pubitemid 28082065)
6. Kaye PM, Gorak P, Murphy M, Ross S. Strategies for immune intervention in visceral leishmaniasis. Ann Trop Med Parasitol 1995; 89(Suppl 1): 75-81. (Pubitemid 26030070)
7. Forget G, Gregory DJ, Whitcombe LA, Olivier M. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide produc-tion. Infect Immun 2006; 74: 6272-6279. (Pubitemid 44657407)
8. Murphy M, Engwerda CR, Gorak PMA, Kaye PM. B7-2 blockade enhances T cell responses to Leishmania donovani. J Immunol 1997; 159: 4460-4466. (Pubitemid 127470606)
9. Ghose AC, Halder JP, Pal SC, Mishra BP, Mishra KK. Serological investigation on Indian kala-azar. Clin Exp Immunol 1980; 40: 318-326.
10. Kaye PM, Rogers NJ, Curry AJ, Scott JC. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur J Immunol 1994; 24: 2850-2854. (Pubitemid 24342206)
11. Murray HW, Lu CM, Brooks EB, Fichtl RE, DeVecchio JL, Heinzel FP. Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis. Infect Immun 2003; 71: 6453-6462. (Pubitemid 37337705)
12. Ghosh MK, Ghosh AK, Addy M, Nandy A, Ghose AC Subpopulations of T lymphocytes in the peripheral blood and lymph nodes of Indian kala-azar patients. Med Microbiol Immunol 1996; 185: 183-187. (Pubitemid 27007712)
13. Mukherjee P, Sen PC, Ghose AC Lymph node cells from BALB/c mice with chronic visceral leishmaniasis exhibiting cellular anergy and apoptosis: involvement of Ser/Thr phosphatase. Apoptosis 2006; 11: 2013-2029. (Pubitemid 44691584)
14. Mookerjee A, Sen PC, Ghose AC Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor ß antibody. Infect Immun 2003; 71: 2439-2446. (Pubitemid 36519855)
15. Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR et al. Transforminggrowthfactor-beta in leishmanial infection: a parasiteescape mechanism. Science 1992; 257: 545-548.
16. Rodrigues V, Silva JS, Campos-Neto A. Transforming growth factor b and immunosup-pression in experimental visceral leishmaniasis. Infect Immun 1998; 66: 1233-1236. (Pubitemid 28101169)
17. Ozturk SS, Hu WS. Cell Culture Technology for Pharmaceutical and Cell-based Therapies. CRC press: Florida, 2006.
18. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-beta: biological function and chemical structure. Science 1986; 233: 532-534. (Pubitemid 16019904)
19. Park IK, Shultz LD, Letterio JJ, Gorham JD. TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the proteintyrosine phosphatase Src homology region 2 domain-contain in gphosphatase-1. J Immunol 2005; 175: 5666-5674. (Pubitemid 41508048)
20. Bright JJ, Sriram S. TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol 1998; 161: 1772-1777. (Pubitemid 28387596)
21. Schuster N, Krieglstein K. Mechanisms of TGF-β.-mediated apoptosis. Cell Tissue Res 2002; 307: 1-14.
22. Taketo MM, Takaku K. Gastro-intestinal tumorigenesis in Smad4 mutant mice. Cytokine Growth Factor Rev 2000; 11: 147-157. (Pubitemid 30169735)
23. Yamaguchi K, Nagai S, Ninomiya TJ, Nishita M, Tamai K, Irie K et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway EMBOJ1999; 18: 179-187. (Pubitemid 29005034)
24. Engel ME, McDonnell MA, Law BK, Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-b-mediated transcription. J Biol Chem 1999; 274: 37413-37420.
25. Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, Mallick S et al. IL-10-and TGF-beta-mediated susceptibility in kala-azarand post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol 2007; 179: 5592-5603.
26. Melby PC, Tryon VV, Chandrasekar B, Freeman GL. Cloning of Syrian Hamster (Mesocricetus auratus) Cytokine cDNAs and Analysis of Cytokine mRNA Expression in Experimental Visceral Leishmaniasis. Infect Immun 1998; 66: 2135-2142. (Pubitemid 28194113)
27. Blanchette J, Racette N, Faure R, Siminovitch KA, Olivier M. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-g-triggered JAK2 activation. Eur J Immunol 1999; 29: 3737-3744. (Pubitemid 29527823)
28. Nandan D, Knutson KL, Raymond L, Reiner NE. Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis. J Leukoc Biol 2000; 67: 464-470.
29. Forget G, Siminovitch KA, Brochu S, Rivest S, Radzioch D, Olivier M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immunol 2001; 31: 3185-3196. (Pubitemid 33100510)
30. José ET, Barbara JM. Entamoeba histolytica-induced dephosphorylation in host cells. Infect Immun 2002; 70: 1816-1823.
31. Sim S, Kim KA, Yong TS, Park SJ, Im KI, Shin MH. Ultrastructural observation of human neutrophils during apoptotic cell death triggered by Entamoeba histolytica. Korean J Parasitol 2004; 42: 205-208.
32. Hallé M, Tremblay ML, Meng TC. Protein tyrosinephosphatases, emerging regulatorsof apoptosis. Cell Cycle 2007; 6: 2773-2781.
33. Wanderley JLM, Benjamin A, Real F, Bonomo A, Moreira MEC, Barcinski MA. Apoptotic mimicry: analtruistic behavior in host/Leishmaniainterplay. Braz J Med Biol Res 2005; 38: 807-812. (Pubitemid 40932233)
34. Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, Klinger M et al. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci USA 2006; 103: 13837-13842. (Pubitemid 44413994)
35. Lindoso JA, Cotrim PC, Goto H. Apoptosis of Leishmania chagasi amastigotes in hamsters infectedwith visceral leishmaniasis. Int J Parasitol 2004; 34: 1-4. (Pubitemid 38056608)
36. Antonio L, Massague J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 1997; 387:417-422. (Pubitemid 27227208)
37. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M. Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol 2003; 285: L492-L499. (Pubitemid 36909467)
38. Genestier L, Kasibhatla S, Brunner T, Green DR. Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in Tcells via downregulation of c-Myc. J Exp Med 1999; 189: 231-239. (Pubitemid 29063245)
39. Guido K, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163. (Pubitemid 46209992)
40. DiCorleto PE. Protein tyrosine phosphatases in the vessel wall: counterpoint to the tyrosine phosphatases. Arterioscler Thromb Vasc Bio 2000; 20: 1179-1181.
41. Blanchette J, Pouliot P, Olivier M. Role of protein tyrosine phosphatases in the regulation of interferon-γ-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation. J Leukoc Biol 2007; 81: 835-844. (Pubitemid 46393562)
42. Pathak MK, Yi T. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol 2001; 167: 3391-3397. (Pubitemid 32852583)
43. Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and-resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for Mixed Th1-and Th2-Like responses in visceral leishmaniasis. J Immunol 2005; 174: 7160-7171. (Pubitemid 40705683)
44. Cossarizza A, Baccarani CM, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1,3,3'- tetraethylbenzimidazolcarbo-cyanine iodide (JC-1). Biochem Biophys Res Commun 1993; 197: 40-45. (Pubitemid 23358874)